Surrounding belt for preventing allergy of infantile navel adhesive tape

Abstract

The invention relates to the technical field of infant nursing materials, in particular to a shroud ring for preventing allergy of an infant navel adhesive tape. Comprising a flexible shroud ring body which is formed by blending 60%-70% of combed cotton and 30%-40% of modal fibers, and a lining layer is made of tencel antibacterial fabric containing 2%-6% of mint essence; a medicine positioning structure is arranged on the surface of the girdle main body, the edge of the girdle main body is subjected to a laser cutting and edge covering process, and the diameter of the positioning structure is 0.8-3.5 cm; a breathable medicine bag covering the positioning structure is arranged in the middle of the girdle main body, the medicine bag adopts a four-thread seaming seamless process, and a sewing thread is made of degradable polylactic acid fibers; the invention provides the girdle capable of preventing the allergy of the child navel adhesive tape, which is capable of avoiding the allergy of the adhesive tape, breathable, comfortable, accurate in medicine positioning, firm, adjustable, antibacterial, slow-release, environment-friendly, safe, convenient to use, multifunctional and adaptive.

Description

TECHNICAL FIELD

[0001] The present application relates to the technical field of infant care products, specifically to a waistband for preventing infant umbilical paste from causing allergies. BACKGROUND

[0002] Currently, infant umbilical paste is a common external paste for children, mainly used to relieve symptoms such as abdominal pain, diarrhea, and indigestion. Traditional umbilical paste is usually composed of medical adhesive tape and a drug layer. When used, the drug part is aligned with the umbilical part, and the adhesive tape is directly pasted on the skin. Some products are also equipped with an anti-allergic non-woven fabric layer to reduce the irritation of the adhesive tape to the skin. However, the existing infant umbilical paste has the following problems in actual use:

[0003] 1. High risk of adhesive tape allergy: Traditional umbilical paste relies on adhesive to fix, and the skin of infants and young children is delicate. Long-term pasting can easily cause allergic reactions such as contact dermatitis, redness, and itching.

[0004] 2. Poor air permeability: The adhesive tape material is mostly non-breathable plastic film or ordinary non-woven fabric. Long-term coverage of the umbilical part may cause local skin to be damp and hot, increasing the risk of infection.

[0005] 3. Uneven drug contact: The drug layer directly contacts the skin, but it is easy to shift during application, resulting in uneven distribution of drug effect and affecting treatment effect.

[0006] 4. Unreliable fixation: Infants and young children have a large amount of activity, and traditional umbilical paste is easy to fall off due to actions such as turning over and crawling, and needs to be frequently replaced, increasing the cost of use.

[0007] 5. Inconvenient adjustment: Most umbilical paste is designed for one-time use, and the tightness cannot be adjusted according to the child's waist circumference. If it is too tight, it may hurt the skin, and if it is too loose, it may easily fall off.

[0008] 6. Lack of antibacterial protection: Ordinary umbilical paste has no antibacterial design. The umbilical part is an area prone to infection, and long-term pasting may breed bacteria, which is not conducive to the care of wounds or sensitive skin.

[0009] 7. Fast drug evaporation: The drug layer of some umbilical paste is exposed to the air, and the active ingredients are easy to evaporate, resulting in short drug effect duration.

[0010] 8. Pain when removed: Strong adhesive tape may damage the skin when removed, especially causing discomfort and even crying in infants and young children.

[0011] In view of the above problems, there is an urgent need for a new type of umbilical paste fixing device that can avoid direct contact of adhesive tape with the skin, ensure accurate release of drugs, be breathable and comfortable, and be firmly fixed. SUMMARY

[0012] The technical problem to be solved by the present invention is that traditional umbilical cord patches for children, due to their direct application of adhesive tape, are prone to skin allergies, poor breathability, loose fixation, and uneven drug distribution. Specifically, the adhesive components of existing umbilical cord patches can easily irritate the delicate skin of infants and young children, causing redness, swelling, and itching; the non-breathable material can easily cause stuffiness and humidity, increasing the risk of infection; and because the tightness cannot be flexibly adjusted, they can easily fall off or shift due to children's activities, affecting the efficacy of the drug. The present invention aims to provide an anti-allergic band that is adhesive-free, breathable, comfortable, adjustable, and can precisely position the drug, to overcome the above-mentioned drawbacks.

[0013] To solve the above technical problems, the technical solution adopted by the present invention is as follows: a band for preventing umbilical cord adhesive allergies in children, comprising a flexible band body made of a blend of 60%-70% combed cotton and 30%-40% modal fiber, and an inner lining of Tencel antibacterial fabric containing 2%-6% mint essence; a drug positioning structure is provided on the surface of the band body, the edge of which is laser-cut and hemmed, and the diameter of the positioning structure is 0.8-3.5 cm; a breathable medicine pouch is provided in the middle of the band body, covering the positioning structure, and the medicine pouch is seamlessly hemmed using a four-thread lockstitch process, and the sutures are made of degradable polylactic acid fiber; and the two ends of the band body are configured with one of the following connection methods:

[0014] Buckle type: 3-5 adjustment buckles on one end and matching buckle slots on the other end;

[0015] Lace-up style: widened straps extending 25-60cm at both ends;

[0016] Velcro: Set a Velcro combination with a width of 4-6 cm, and the bonding area is 25%-40% of the circumference of the belt;

[0017] Magnetic buckle type: rare earth magnets are embedded at both ends with a spacing of 1.5-2.5cm, and the diameter of a single magnet is 6-10mm;

[0018] Hook type: an elastic silicone hook is set on one end and a ring adjustment belt is set on the other end.

[0019] As a further solution of the present invention: the drug positioning structure has one of the following layouts:

[0020] Single-point type: A single circular positioning structure is located in the center of the capsule, 1-2 cm from the edge;

[0021] Three-point type: three positioning structures with a diameter of 1.5-2.5 cm are arranged linearly with a center spacing of 3-5 cm;

[0022] Five-star type: Five positioning structures are distributed radially, with the central structure having a diameter of 2.5-3.5 cm and the peripheral structures having a diameter of 1.5-2.5 cm.

[0023] As a further solution of the present invention: the width of the belt body is adjustable from 6 to 18 cm, the surface of the inner lining layer has a sustained-release coating with a thickness of 0.08 to 0.12 mm, containing 0.05% to 0.1% tea polyphenols antibacterial ingredients; the contact surface of the Velcro connection adopts a 3D breathable mesh structure.

[0024] As a further solution of the present invention: a U-shaped opening is provided on the top of the medicine bag, and a medical-grade TPU support strip is built into the opening; the umbilical cord adhesive is placed in the medicine bag through the opening, and a compound preparation containing 0.5-20 grams of perilla extract, 0.5-20 grams of tangerine peel extract, and 0.5-20 grams of mugwort extract can be placed in the drug positioning structure.

[0025] As a further solution of the present invention: its preparation method comprises:

[0026] S1. Material treatment: blended fabrics are subjected to ecological dyeing at 50-60℃ for 30 minutes and then neutralized; Tencel fabrics are immersed in mint extract at 35-40℃ for 1-2 hours;

[0027] S2. Functional treatment: Use nano-microcapsule technology to spray the antibacterial layer, and control the curing temperature in the range of 38-42℃;

[0028] S3. Molding process: The positioning structure adopts 0.15-0.20mm precision edging, the key parts adopt double cross reinforcement sewing, and the magnetic buckle belt is implanted in the magnet protection cabin during the molding stage.

[0029] Compared with the prior art, the present invention has the following beneficial effects:

[0030] 1. Avoid tape allergies: The flexible belt body is used instead of traditional tape to completely avoid direct contact between adhesive and skin, fundamentally preventing allergic reactions, especially suitable for infants and young children with sensitive skin.

[0031] 2. Breathable and comfortable: The main body of the band is made of a blended fabric of 60%-70% combed cotton and 30%-40% modal fiber, and the lining is Tencel antibacterial fabric. It is also equipped with breathable medicine bags and 3D grid structure to ensure that the skin is dry and breathable, reducing the risk of stuffiness and infection.

[0032] 3. Accurately position the drug: Through the drug positioning structure (single-point, three-point or five-star layout) and breathable drug bag design, the drug can stably cover the navel to avoid displacement and ensure uniform release of drug efficacy.

[0033] 4. Firm and adjustable: It provides five connection methods: buckle, lace-up, Velcro, magnetic buckle and hook. The tightness can be flexibly adjusted according to the child's waist circumference, which can prevent it from falling off and avoid squeezing the skin.

[0034] 5. Antibacterial sustained release: The inner lining contains mint essence and tea polyphenols antibacterial ingredients, combined with nano-microcapsule sustained release technology, which can inhibit bacterial growth in a long term while providing a cooling and soothing effect.

[0035] 6. Environmental protection and safety: The stitching is made of biodegradable polylactic acid fiber, and the magnetic buckle design uses rare earth magnets to ensure that it is non-toxic and harmless and meets the safety standards for infant products.

[0036] 7. Easy to use: The top of the medicine bag is equipped with a U-shaped opening and a TPU support strip, which facilitates the quick replacement of the navel patch; the laser-cut edging and double-cross reinforcement process improve durability and are suitable for long-term use.

[0037] 8. Multifunctional adaptation: supports different combinations of medicinal materials (such as perilla, tangerine peel, and mugwort extracts), and can be used with various navel patch medicines to meet diverse treatment needs. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:

[0039] Figure 1 This is a schematic diagram of a buckle single-point belt structure for preventing umbilical cord adhesive allergies in children. Figure 1 .

[0040] Figure 2 This is a schematic diagram of a buckle single-point belt structure for preventing umbilical cord adhesive allergies in children. Figure 2 .

[0041] Figure 3 This is a schematic diagram of the buckle three-point belt structure of the belt for preventing umbilical cord adhesive allergies in children according to the present invention. Figure 1 .

[0042] Figure 4 This is a schematic diagram of the buckle three-point belt structure of the belt for preventing umbilical cord adhesive allergies in children according to the present invention. Figure 2 .

[0043] Figure 5 This is a schematic diagram of the buckle five-star belt structure of a belt for preventing umbilical cord adhesive allergies in children according to the present invention. Figure 1 .

[0044] Figure 6 This is a schematic diagram of the buckle five-star belt structure of a belt for preventing umbilical cord adhesive allergies in children according to the present invention. Figure 2 .

[0045] Figure 7 The present invention provides a comparative bar chart of related indicators of different types of umbilical cord adhesive allergy prevention bandages for children.

[0046] In the attached figure:

[0047] 1. Belt body; 2. Drug positioning structure; 3. Drug sac; 4. Adjustment buckle; 5. Buckle slot. DETAILED DESCRIPTION

[0048] The following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of the present invention.

[0049] See also Figure 1-7

[0050] Example 1 (Snap-on + Single-point)

[0051] Structural features:

[0052] The belt body is made of a blend of 65% combed cotton and 35% modal fiber, with a thickness of 0.8mm. The single-point circular positioning structure has a diameter of 2.5cm and is laser-cut.

[0053] The adjustment buckle is made of medical-grade ABS plastic, with a spacing of 2cm and a total of 4 adjustment positions;

[0054] The volume of the medicine capsule is 5ml, containing 3g of perilla extract and 2g of tangerine peel extract.

[0055] Performance data:

[0056] 12-hour displacement test: 0.3±0.1cm;

[0057] Air permeability: 480±20CFM (ASTMD737 standard);

[0058] 6-hour drug release rate: 82±3%;

[0059] Antibacterial rate: The inhibition rate against Escherichia coli is >99.5%.

[0060] Example 2 (Hook-and-loop + Three-point Type)

[0061] Structural features:

[0062] Three-point linear arrangement with a center distance of 4cm;

[0063] The positioning structure has a diameter of 2cm and adopts a double-layer edging process;

[0064] The medicine bag is divided into three independent chambers, each with a volume of 3ml.

[0065] Performance data:

[0066] Displacement: 0.5±0.2cm;

[0067] Air permeability: 460±15CFM;

[0068] Drug release uniformity: The difference between each point was <5%.

[0069] Example 3 (Snap-on + Five-Star Style)

[0070] Structural features:

[0071] Five-star radial layout, the central positioning structure has a diameter of 3cm;

[0072] The four positioning points around the periphery are 2 cm in diameter and distributed at 90°;

[0073] The medicine capsule adopts a star-shaped partition design.

[0074] Performance data:

[0075] Drug coverage area: 150% more than single-point type;

[0076] Air permeability: 440±10CFM;

[0077] 12-hour efficacy maintenance rate: 92%.

[0078] Example 4 (lace-up + single-point style)

[0079] Structural features:

[0080] Lace width 3cm, length 50cm;

[0081] The single-point positioning structure has a breathable hole (aperture 0.5mm); the opening of the medicine bag adopts an elastic closing design.

[0082] Performance data:

[0083] Maximum adjustment range: 45-65cm;

[0084] Displacement: 1.2±0.3cm;

[0085] Air permeability: 520±25CFM.

[0086] Example 5 (lace-up + three-point style)

[0087] Structural features:

[0088] The three-point positioning structure is arranged in an arc shape;

[0089] There is a non-slip silicone strip at the end of the laces;

[0090] The medicine capsule adopts wave-shaped partitions.

[0091] Performance data:

[0092] Displacement: 1.5±0.4cm;

[0093] Air permeability: 500±20CFM;

[0094] Drug diffusion speed: 20% faster than single-point type.

[0095] Example 6 (lace-up + five-star style)

[0096] Structural features:

[0097] Five-star layout with central breathable mesh;

[0098] The straps are designed with gradient width (3-5cm); the medicine sac has a five-petal structure.

[0099] Performance data:

[0100] Drug contact area: 18cm 2 ;

[0101] Air permeability: 480±15CFM;

[0102] Fit rating: 4.8 / 5.0.

[0103] Example 7 (Hook and Loop + Single Point)

[0104] Structural features:

[0105] The Velcro adopts mushroom head structure;

[0106] Single point positioning with annular ventilation groove;

[0107] The opening of the medicine bag is provided with a TPU support strip.

[0108] Performance data:

[0109] Opening and closing life: >500 times;

[0110] Displacement: 0.2±0.1cm;

[0111] Air permeability: 580±30CFM.

[0112] Structural features of embodiment 8 (velcro + three-point)

[0113] Three-point positioning with micro-ventilation holes; Velcro contact surface contains antibacterial coating; the medicine bag partition wall is 0.5mm thick.

[0114] Performance data:

[0115] Antimicrobial persistence: >30 days;

[0116] Displacement: 0.4±0.2cm;

[0117] Air permeability: 560±25CFM.

[0118] Structural features of embodiment 9 (velcro + five-star style):

[0119] Five-star layout with a central observation window; Velcro adopts a zoned adhesive design; the medicine capsule is in the shape of a five-pointed star.

[0120] Performance data:

[0121] Drug release uniformity: CV<3%; air permeability: 540±20 CFM; clinical efficacy: 98.2%.

[0122] Structural features of embodiment 10 (magnetic buckle + single-point type):

[0123] Neodymium magnet N35 grade, nickel-plated surface; single point positioning with magnetic shielding layer;

[0124] The medicine capsule is designed to prevent magnetic interference.

[0125] Performance data:

[0126] Magnetic attraction: 0.8N / cm 2 ;

[0127] Displacement: 0.1±0.05cm;

[0128] Air permeability: 420±15 CFM. Structural features of Example 11 (magnetic buckle + three-point type):

[0129] Three-point positioning with magnetic balancer; magnet spacing is adjustable;

[0130] The medicine capsule is anti-magnetic treated.

[0131] Performance data:

[0132] Magnetic stability: ±5%;

[0133] Displacement: 0.3±0.1cm;

[0134] Air permeability: 400±10 CFM. Structural features of Example 12 (magnetic buckle + five-star style):

[0135] Five-star magnetic distribution system;

[0136] The central magnet has a diameter of 12 mm;

[0137] The five areas of the medicine bag are independently sealed.

[0138] Performance data:

[0139] Magnetic positioning accuracy: ±0.5mm; air permeability: 380±8CFM;

[0140] Drug non-interference rate: 100%. Example 13 (hook type + single point type) structural features:

[0141] Silicone hook with Shore hardness of 50A; single-point positioning with anti-slip grooves;

[0142] Medicine capsule quick release design.

[0143] Performance data:

[0144] Hook load-bearing capacity: >5kg;

[0145] Displacement: 0.8±0.3cm;

[0146] Air permeability: 490±20 CFM. Structural features of Example 14 (hook-type + three-point type):

[0147] Three-point positioning with guide groove;

[0148] Double hook symmetrical design;

[0149] The medicine bag has a three-way opening.

[0150] Performance data:

[0151] Positioning accuracy: ±1mm;

[0152] Air permeability: 470±15CFM; Ease of replacement: 4.5 / 5.0.

[0153] Structural features of embodiment 15 (hook type + five-star type):

[0154] Five-star positioning with angle adjustment; elastic hook system;

[0155] Modular design of medicine capsule.

[0156] Performance data:

[0157] Multi-angle adaptability: ±15°; Air permeability: 450±12CFM; Clinical satisfaction: 97.5%.

[0158] Comparative Analysis Table

[0159] Comparison indicators Single point Three-point Five-star Optimal solution Drug coverage <![CDATA[5-8cm 2 ]]> <![CDATA[12-15cm 2 ]]> <![CDATA[18-22cm 2 ]]> Five-star Breathability 480-580 CFM 460-560 CFM 380-540CFM Single point Fixed stability Displacement 0.1-1.2cm Displacement 0.3-1.5cm Displacement 0.5-1.8cm Magnetic buckle single point Adjustment convenience medium good excellent Five-star Cost-effectiveness ￥15-20 ￥20-25 ￥25-35 Single point Applicable Scenarios Light Care Conventional treatment Severe illness treatment Select on demand

[0160] Item comparison table

[0161] Connection method comparison

[0162] type <![CDATA[固定力(N / cm 2 )]]> Adjustment accuracy (mm) Service life (times) Applicable age Buckle 0.5-0.8 ±2 300 3-12 months Lace-up 0.3-0.6 ±5 ∞ 0-24 months Velcro 0.7-1.0 ±1 500 6-18 months Magnetic buckle 1.2-1.5 ±0.5 1000 3-18 months Hook type 0.4-0.7 ±3 200 6-12 months

[0163] Comparison of positioning methods

[0164]

[0165]

[0166] Optimization suggestions

[0167] 1. For critically ill patients: The magnetic buckle + five-star combination is preferred. Although the cost is higher (about ￥32), it has the best fixation stability (displacement is only 0.5cm) and drug coverage (22cm 2 )

[0168] 2. Newborn care: We recommend the lace-up + single-point type, which has a wide adjustment range (45-65cm) and the lowest cost (￥15)

[0169] 3. Summer use: Choose the Velcro + three-point type, which has good air permeability (560CFM) and moderate drug release rate.

[0170] 4. Economical solution: buckle type + single point combination, balancing cost (￥18) and performance (displacement 0.3cm)

[0171] The present invention and its embodiments are described above. This description is not restrictive. The drawings show only one embodiment of the present invention, and the actual structure is not limited thereto. In short, if a person skilled in the art is inspired by this and, without departing from the purpose of the present invention, designs structures and embodiments similar to this technical solution without inventiveness, they shall fall within the scope of protection of the present invention.

Claims

1. A band for preventing umbilical cord adhesive allergies in children, characterized by: The invention comprises a flexible belt body (1), which is made of a blend of 60%-70% combed cotton and 30%-40% modal fiber, and an inner lining layer of Tencel antibacterial fabric containing 2%-6% mint essence; a drug positioning structure (2) is provided on the surface of the belt body (1), the edge of which adopts a laser cutting and hemming process, and the diameter of the positioning structure is 0.8-3.5 cm; a breathable medicine bag (3) covering the positioning structure is provided in the middle of the belt body (1), and the medicine bag adopts a four-thread lock-edge seamless process, and the suture is made of degradable polylactic acid fiber; and the two ends of the belt body (1) are configured with one of the following connection methods: Buckle type: 3-5 adjustment buckles (4) are provided on one end, and a matching buckle slot (5) is provided on the other end; Lace-up style: widened straps extending 25-60cm at both ends; Velcro: Set a Velcro combination with a width of 4-6 cm, and the bonding area is 25%-40% of the circumference of the belt; Magnetic buckle type: rare earth magnets are embedded at both ends with a spacing of 1.5-2.5cm, and the diameter of a single magnet is 6-10mm; Hook type: an elastic silicone hook is set on one end and a ring adjustment belt is set on the other end.

2. The bandage for preventing umbilical cord adhesive allergy in children according to claim 1, characterized in that: The drug positioning structure (2) is one of the following layouts: Single-point type: a single circular positioning structure is located in the center of the medicine bag (3), 1-2 cm away from the edge; Three-point type: three positioning structures with a diameter of 1.5-2.5 cm are arranged linearly with a center spacing of 3-5 cm; Five-star type: Five positioning structures are distributed radially, with the central structure having a diameter of 2.5-3.5 cm and the peripheral structures having a diameter of 1.5-2.5 cm.

3. The bandage for preventing umbilical cord adhesive allergy in children according to claim 1, characterized in that: The width of the belt body (1) is adjustable from 6 to 18 cm, and the surface of the inner lining layer has a sustained-release coating with a thickness of 0.08 to 0.12 mm, containing 0.05% to 0.1% tea polyphenol antibacterial ingredients; the contact surface of the Velcro connection adopts a 3D breathable mesh structure.

4. The bandage for preventing umbilical cord adhesive allergy in children according to claim 1, characterized in that: The top of the medicine bag (3) is provided with a U-shaped opening, and a medical-grade TPU support strip is built into the opening; the umbilical adhesive is placed in the medicine bag (3) through the opening, and a compound preparation containing 0.5-20 grams of perilla extract, 0.5-20 grams of tangerine peel extract, and 0.5-20 grams of wormwood extract can be placed in the medicine positioning structure (2).

5. The bandage for preventing umbilical cord adhesive allergy in children according to claim 1, characterized in that: The preparation method thereof comprises: S1. Material treatment: blended fabrics are subjected to ecological dyeing at 50-60℃ for 30 minutes and then neutralized; Tencel fabrics are immersed in mint extract at 35-40℃ for 1-2 hours; S2. Functional treatment: Use nano-microcapsule technology to spray the antibacterial layer, and control the curing temperature in the range of 38-42℃; S3. Molding process: The positioning structure adopts 0.15-0.20mm precision edging, the key parts adopt double cross reinforcement sewing, and the magnetic buckle belt is implanted in the magnet protection cabin during the molding stage.

Images